โฌค Loadingโ€ฆ

โญ US Superinvestors

Track SEC Form 13F portfolios of 14 legendary fund managers โ€” Warren Buffett, Bill Ackman, Michael Burry, Stan Druckenmiller, Cathie Wood, and more. Data sourced directly from EDGAR, updated quarterly.

โฑ 45-day lag: Q1 2026 data (ending Mar 31) available from May 15, 2026 per SEC rules.

DL

Daniel Loeb

Third Point LLC

Activist Event-driven
33 stocks $2.08T as of Mar 2026
View Portfolio โ†’
WB

Warren Buffett

Berkshire Hathaway Inc

Value Long-term
90 stocks $263.1B as of Mar 2026
View Portfolio โ†’
SC

Steve Cohen

Point72 Asset Management

Multi-strategy
3704 stocks $78.1B as of Mar 2026
View Portfolio โ†’
JS

Jim Simons

Renaissance Technologies LLC

Quant Systematic
3213 stocks $63.9B as of Mar 2026
View Portfolio โ†’
AH

Andreas Halvorsen

Viking Global Investors

Growth Event-driven
77 stocks $35.7B as of Mar 2026
View Portfolio โ†’
TM

Tiger Global Management

Tiger Global Management LLC

Growth Tech
54 stocks $22.8B as of Mar 2026
View Portfolio โ†’
BA

Bill Ackman

Pershing Square Capital Management

Activist Value
11 stocks $13.7B as of Mar 2026
View Portfolio โ†’
CW

Cathie Wood

ARK Investment Management

Growth Disruptive Innovation
182 stocks $12.9B as of Mar 2026
View Portfolio โ†’
DT

David Tepper

Appaloosa LP

Macro Distressed
31 stocks $5.9B as of Mar 2026
View Portfolio โ†’
JU

Jeff Ubben

ValueAct Holdings

Activist Value
18 stocks $5.7B as of Mar 2026
View Portfolio โ†’
SK

Seth Klarman

Baupost Group

Deep Value Special Situations
22 stocks $5.1B as of Mar 2026
View Portfolio โ†’
SD

Stan Druckenmiller

Duquesne Family Office

Macro Growth
70 stocks $3.4B as of Mar 2026
View Portfolio โ†’
LL

Li Lu

Himalaya Capital Management

Value Asia
14 stocks $3.2B as of Mar 2026
View Portfolio โ†’
MB

Michael Burry

Scion Asset Management

Contrarian Value
8 stocks $1.4B as of Sep 2025
View Portfolio โ†’

๐Ÿ“Š Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagineโ„ข Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

๐ŸŽฏ
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
๐Ÿ“Š Explore The Finmagineโ„ข Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions โ€” revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex โ€” are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = ฮฃ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 ร— (1+g) / (WACCโˆ’g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 โˆ’ 1. Assumes fair value is reached in exactly 5 years โ€” a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

โš ๏ธ Important Disclaimers โ€” Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.